Ferritin Quantitative Test

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any significant rise in serum creatinine.

Product Detail

Product Specification

Specimen Types
Urine
Specimen Capacity
10μL
Reaction Time
10min
Sample Capacity
80μL
Detection Range
10-5000ng/mL



Clinical Significance

Acute kidney injury (AKI) is one of the major causes of morbidity and mortality encountered by hospitalized patients, especially intensive care centers. Early detection may improve the hospital stay, patients prognosis, and reduce expensive medical costs.
Cited from: Cai-Mei Zheng, Min-Tser Liao et al.,“ Biomarkers in Acute
Kidney Injury”, Open Journal of Nephrology, Vol.3 No.1(2013).



Aplication

  • Early diagnosis of AKI to allow earlier initiation of appropriate management
  • Risk stratification of AKI
  • Prediction of clinical outcomes (dialysis, in-hospital death, length of hospital stay, mortality)
  • Monitor response to therapy

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
Biotime HbA1c Rapid Quantitative Test
HbA1c Rapid Quantitative Test
HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.
biotime MAU Rapid Quantitative Test
MAU Rapid Quantitative Test
MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.
Cys C Rapid Quantitative Test
Cys-C Rapid Quantitative Test
Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.
Biotime HbA1c Rapid Quantitative Test
HbA1c Rapid Quantitative Test
HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.
Dengue Ag&Ab Combo  Rapid Test
Dengue Ag&Ab Combo Rapid Test
The Dengue Ag&Ab Combo Rapid Test is a rapid membrane based chromatographic immunoassay for for the qualitative detection of NS1 antigen and IgM/IgG antibodies to all four serotypes (DEN-1, DEN-2, DEN-3 and DEN-4) of Dengue virus in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of primary and secondary Dengue infection. For professional in vitro diagnostic use only.
CRP Rapid Quantitative Test (Chemiluminescence Immunoassay)
CRP Rapid Quantitative Test (Chemiluminescence Immunoassay)
CRP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-reactive proteins (CRP) concentration in human serum, plasma and vein whole blood specimens.
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the 25-hydroxyvitamin D (25 (OH) D) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of health check.
Biotime ST2 Rapid Quantitative Test
ST2 Rapid Quantitative Test
ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact